Getting medicine in Nigeria is not always as simple as walking into a pharmacy.

For patients in underserved and semi-urban communities, the nearest reliable pharmacy may be difficult to reach. Even when medicines are available, patients can face another problem: knowing whether a product is genuine, appropriate for their symptoms and being dispensed correctly.

Nigerian healthtech startup Mariam Grey is trying to tackle that gap by combining artificial intelligence, remote pharmacists, digital consultations and a network of physical pharmacies.

Founded in 2018 by licensed pharmacist Jennifer Esiaba, Mariam Grey has developed a digital healthcare platform that connects patients with verified pharmacies and licensed pharmacists remotely.

The company says it has now crossed 9,000 active paying patients across multiple Nigerian states, working with hundreds of partner pharmacies.

Rather than positioning itself solely as an online pharmacy, Mariam Grey describes its model as an AI-enabled integrated community healthcare platform.

AI That Connects Patients to Human Pharmacists

One of the platform's central tools is an AI assistant called Mummy Grey.

The assistant can recommend over-the-counter medicines based on symptoms and screen uploaded prescriptions before they are routed to a pharmacist for confirmation.

It can also help patients book consultations with doctors.

That human layer is important.

Healthcare is an area where AI recommendations can have serious consequences if they are treated as a substitute for professional medical judgment. Mariam Grey's model therefore uses AI as an initial layer of guidance while routing clinically serious issues to a real pharmacist.

The result is closer to a human-in-the-loop healthcare model than a fully automated medical chatbot.

Patients can begin the process digitally, while licensed professionals remain involved where clinical confirmation is required.

Mariam Grey Is Also Built for People Without Smartphones

Perhaps one of the more important parts of Mariam Grey's strategy is what happens when a patient does not have a smartphone or reliable internet connection.

The company has built a USSD channel that allows patients to access its services without depending on mobile data or a modern smartphone.

That matters in Nigeria because digital healthcare can easily become concentrated among urban, smartphone-owning consumers.

An app-first model may work well for someone with a reliable internet connection, but it can leave out the very communities that face some of the biggest healthcare-access challenges.

Mariam Grey is attempting to reduce that gap through USSD, multilingual support and its physical pharmacy network.

The company says it supports customers in multiple languages and works with hundreds of partner pharmacies across several states.

Building a Healthcare Network, Not Just an Online Pharmacy

The platform's services extend well beyond ordering medicine.

Mariam Grey combines several components of healthcare delivery, including:

  • Verified pharmacy inventory aggregation

  • Remote pharmacy consultations

  • Home medicine delivery

  • Home laboratory sample collection

  • Digital doctor consultations

  • AI-powered medication guidance

  • HMO integration

  • Community health programmes

  • A distributed pharmacy network

This gives the company a broader role in the healthcare journey.

A patient might begin with a symptom, use Mummy Grey for an initial recommendation, have the request reviewed by a pharmacist, order medication from a partner pharmacy and receive it at home.

Another patient may require a doctor consultation or laboratory service instead.

That integrated model is designed to reduce the number of separate steps patients have to navigate.

The Last-Mile Healthcare Problem

Mariam Grey's strategy is built around a problem that is larger than pharmacy e-commerce.

Nigeria has a large and highly fragmented healthcare system, and physical access remains uneven across locations.

For patients outside major urban centres, finding a trusted pharmacy, accessing a doctor or confirming whether a medication is appropriate can involve considerable time and travel.

Founder Jennifer Esiaba argues that many existing digital health products have primarily been designed around smartphone-owning, urban and English-speaking consumers.

Mariam Grey is deliberately targeting a broader group.

Its USSD channel addresses connectivity and device limitations. Multilingual support addresses language barriers. Its pharmacy network provides a physical layer that complements the digital platform.

The strategy is effectively to use technology to make the existing healthcare infrastructure more accessible rather than trying to replace it entirely.

9,000 Paying Patients and a Loyalty Strategy

The approach appears to be gaining traction.

Mariam Grey says it has reached more than 9,000 active paying patients across multiple Nigerian states.

The startup has also introduced a subscription model and its Grey Card loyalty programme, which includes four tiers, with the highest level branded Grey Elite VIP.

The goal is to turn individual transactions into longer-term patient relationships.

That could become particularly important for a digital health business because acquiring a patient for a single medicine order is different from building a service that patients repeatedly use for medication, consultations, laboratory services and other healthcare needs.

Recurring subscriptions can also provide a more predictable revenue stream than relying entirely on individual transactions.

Mariam Grey currently generates revenue through patient orders, alongside recurring subscription revenue from its loyalty programme.

From Bootstrapping to a $350,000 Fundraise

Mariam Grey has been bootstrapped to date and has also received support from angel investors through SAFE agreements.

The startup is now seeking $350,000 in pre-seed funding.

The company plans to use the capital to accelerate product development, strengthen its technology infrastructure and expand operations across Nigeria.

Its immediate goal is to grow from its current patient base to 20,000 active patients within the next 18 months.

Longer term, the company is targeting more than 300,000 patients nationwide.

That expansion will test whether its pharmacy-partner model can maintain consistent service quality while operating across a much larger geographic footprint.

Paediatric Care Is the First New Vertical

Mariam Grey is also beginning to expand beyond its core offering.

Its first vertical expansion is Horient Health, which focuses on paediatric care.

The company sees this as a model that could eventually be replicated across other healthcare conditions or demographic groups.

Rather than building a completely separate healthcare business each time, the underlying idea is to use Mariam Grey's existing technology, pharmacy relationships and patient infrastructure to create specialised healthcare services.

If successful, that could allow the company to move from digital pharmacy into a broader collection of condition-specific and demographic healthcare platforms.

Trust and Regulation Are Still the Hard Part

For Mariam Grey, technology is only one part of the challenge.

Digital healthcare requires patients to trust that the person, pharmacy or system handling their healthcare needs is legitimate.

The startup says building that trust has required continuous patient education and consistent execution.

Regulation is another challenge.

Healthcare and pharmaceutical services operate within strict regulatory frameworks, and expanding a digital platform across multiple states means maintaining compliance while coordinating a fragmented network of pharmacy partners.

There is also the operational challenge of maintaining consistent quality.

When a platform depends on hundreds of external pharmacies, the customer experience ultimately depends on more than the software. Medicine availability, dispensing standards, fulfilment, delivery and pharmacist responsiveness all become part of the product.

Mariam Grey says it has responded by investing in trusted pharmacy partnerships, regulatory compliance, technology designed for low-resource environments and customer experience.

Those investments could become a competitive advantage if the company manages to maintain them as it scales.

The Bigger Opportunity for African Healthtech

Mariam Grey's model highlights an important reality about African digital healthcare: the biggest opportunity may not be creating a completely digital healthcare system.

It may be connecting the digital and physical systems that already exist.

Nigeria already has pharmacies, doctors, laboratories, community health workers and healthcare institutions. The problem is often fragmentation and uneven access.

Technology can potentially serve as the coordination layer between them.

Mariam Grey is betting that AI can make that layer more efficient, while USSD ensures that access does not depend entirely on smartphones and broadband.

But the company's long-term success will depend on whether it can scale this model without compromising clinical safety, regulatory compliance, medicine quality and patient trust.

For a startup targeting 300,000 patients, those issues are not secondary concerns. They are the foundation of the business.